Erectile Dysfunction Treatment Market, by Drugs [Sildenafil (Viagra), Vardenafil (Levitra Staxyn) , Tadalafil (Cialis), Avanafil (Stendra), Udenafil (Zydena), Others] by Route of Administration (Oral drugs, Injection, and Topical application) by Distribut

Erectile Dysfunction Treatment Market, by Drugs [Sildenafil (Viagra), Vardenafil (Levitra Staxyn) , Tadalafil (Cialis), Avanafil (Stendra), Udenafil (Zydena), Others] by Route of Administration (Oral drugs, Injection, and Topical application) by Distribution Channel (Hospital Pharmacies, Offline  Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Erectile dysfunction is the inability to maintain a firm erection during sexual activity. It is a sign of a physical or psychological condition. Erectile dysfunction is caused by stress, age, depression, diabetes, Blood pressure issues or an unhealthy lifestyle. Various treatments are available for erectile dysfunction such as drugs, injections, and topical creams. Market players are indulged in research and development activities for developing drugs for effective results with minimum time consumption. Viagra is one of the most used drugs for erectile dysfunction. Many companies are engaged to receive approval from regulatory authorities for generic medicines which drives the growth of erectile dysfunction treatment market. For instance, in December 2017, Teva Pharmaceuticals which is pharmaceutical manufacturer of high quality generic medicines has received the U.S. Food and Drug Administration (U.S.FDA) approval of generic medicine for Viagra and another generic version of Vardenafil was approved by the U.S.FDA in October 2018.Vardenafill is class of medicine called Phosphodiesterase (PDE) inhibitors which helps in increasing the blood flow to penile tissue to cause erection.

Market Dynamics

Market players are engaged in providing advanced treatments for erectile dysfunction for effective and efficient results. This is expected to increase the growth of the global erectile dysfunction treatment market over the forecast period. For instance, an article published on January 25, 2019 by the National Center for Biotechnology Information (NCBI) states that advanced treatments are available for erectile dysfunction treatment such as penile prosthesis, vacuum-assisted erectile, intraurethral suppository, along with novel therapies such as stem cell therapy, external penile prosthesis, platelet-rich plasma, and penile shockwave therapy, which help to reduce erectile dysfunction in men.

Increasing awareness for the treatment as well as management of erectile dysfunction is expected to increase the growth of the global erectile dysfunction treatment market over the forecast period. For instance, on February 12, 2021, Sexual and Reproductive Health Awareness day was celebrated to raise the awareness for sexual health awareness. This program was started by Canadian government, and it has since spread around the globe. This program aims to provide information to socially and educationally backward population to avoid the serious issues cause due to erectile dysfunction as the prevalence of erectile dysfunction is increasing globally.
This programme was started by the Canadian government, and it has since spread around the world.
Key features of the study:
This report provides an in-depth analysis of global erectile dysfunction treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global erectile dysfunction treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Boston Scientific, Mylan Pharmaceuticals Inc., Cipla Ltd., Pfizer Inc, Coloplast CORP, Eli Lily & Co, Gust Inc., Altera, Promedon , Dr. Reddys Laboratories Ltd., Zephyr Surgical Implants, Pos-T-Vac Inc., Bayer Pharma AG, Reflexonic Llc., Dong-A Pharmaceutical Co. Ltd., Owen Mumford Ltd., Vacurect Manufacturing Ltd., and Silimed.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global erectile dysfunction treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global erectile dysfunction treatment market
Detailed Segmentation:
Global Erectile Dysfunction Treatment Market, By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
Global Erectile Dysfunction Treatment Market, By Route of Administration:
Oral drugs
Injections
Topical application
Global Erectile Dysfunction Treatment Market, By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
Global Erectile Dysfunction Treatment Market, By Region:
North America
By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
By Route of Administration:
Oral drugs
Injections
Topical application
By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
By Route of Administration:
Oral drugs
Injections
Topical application
By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
By Route of Administration:
Oral drugs
Injections
Topical application
By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
By Route of Administration:
Oral drugs
Injections
Topical application
By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
By Route of Administration:
Oral drugs
Injections
Topical application
By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drugs:
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
By Route of Administration:
Oral drugs
Injections
Topical application
By Distribution Channel:
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Boston Scientific *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Mylan Pharmaceuticals Inc.
Cipla Ltd
Pfizer Inc.
Coloplast CORP
Eli Lily & Co,
Gust Inc.
Altera
Promedon
Dr. Reddys Laboratories Ltd
Zephyr Surgical Implants
Pos-T-Vac Inc.
Bayer Pharma AG
Reflexonic Llc.
Dong-A Pharmaceutical Co. Ltd.
Owen Mumford Ltd
Vacurect Manufacturing Ltd
Silimed
“*” marked represents similar segmentation in other categories in the respective section